Ascendis Pharma Net Total Equity Issued/Repurchased 2015-2025 | ASND
Ascendis Pharma net total equity issued/repurchased for the twelve months ending March 31, 2025 was $0.738B, a 1524.01% increase year-over-year.
- Ascendis Pharma annual net total equity issued/repurchased for 2024 was $0.368B, a 3208.87% increase from 2023.
- Ascendis Pharma annual net total equity issued/repurchased for 2023 was $0.011B, a 110.55% decline from 2022.
- Ascendis Pharma annual net total equity issued/repurchased for 2022 was $-0.106B, a 124.93% decline from 2021.